Cargando…
Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
Anaplastic thyroid cancer (ATC) comprises 1-2% of all thyroid cancers and is one of the most aggressive cancers with a median survival rate of around four months. The average 5-year survival rate has been reported to be around 3.6%. In this paper, we have discussed management and prognostic variable...
Autores principales: | Hussain, Nasir, Mustafa, Usman, Jung, Su Hyeon, Gilman, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600220/ https://www.ncbi.nlm.nih.gov/pubmed/23533874 http://dx.doi.org/10.1155/2013/783862 |
Ejemplares similares
-
Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
por: Lee, Haejun, et al.
Publicado: (2020) -
Anaplastic thyroid cancer: multimodal treatment results
por: Aslan, Zaki Antonio Taissoun, et al.
Publicado: (2014) -
Anaplastic thyroid carcinoma with unusual long-term survival: a case report
por: Moreno, Fany, et al.
Publicado: (2022) -
Individualized multimodal treatment strategy for anaplastic thyroid carcinoma—Case report of long-term remission and review of literature
por: Eckhardt, S., et al.
Publicado: (2016) -
Long-term results of radiotherapy in anaplastic thyroid cancer
por: Dumke, Anne-Katrin, et al.
Publicado: (2014)